Breathe Well Live Well
|
LETTER: Asthma attacks
Crawley Observer Pollen and pollution levels are set to rise across the UK meaning people with asthma may find their symptoms get worse which can significantly increase their risk of a potentially fatal asthma attack. People living in urban areas need to take special … |
View full post on asthma – Google News
Newsday |
Letter: Empower students who have asthma
Newsday Newsday recently reported on findings in the journal Pediatrics about trends in asthma among U.S. children [“Study: Kids' asthma rates down,” News, Dec. 28]. While the article leaves one encouraged that asthma rates among many groups have plateaued, … |
View full post on asthma – Google News
|
ALK's Grazax in five-year landmark asthma prevention trial in children sees …
The Pharma Letter (registration) Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass pollen allergy. The GAP trial consisted of a … |
View full post on asthma – Google News
The Pharma Letter (registration) |
GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration) UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the … EU OK for GSK's novel asthma biologic Nucala Now Available for Severe Asthma EU Grants Marketing Authorization to GSK's Nucala |
View full post on asthma – Google News
|
Letter: Proposed plant would hurt people with asthma
My Citizens News There is a shoe organizer in the nurse's office at Andrew Avenue School in Naugatuck. But what inhabits the 24 slots of the shoe rack has nothing to do with shoes. In those slots are 24 nebulizers for children with asthma. There are many reasons to be … |
View full post on asthma – Google News
|
Positive results for Sanofi/Regeneron's dupilumab in asthma
The Pharma Letter French pharma major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals (Nasdaq: REGN) have released positive results from the interim analysis of a dose-ranging Phase IIb study of dupilumab in adult patients with uncontrolled … |
View full post on asthma – Google News
The Pharma Letter |
Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic … |
View full post on asthma – Google News
|
Asthma's treatment pipeline very strong as more personalized medicines emerge
The Pharma Letter According to research and consulting firm GlobalData's latest report, the most significant challenge in asthma therapeutics is posed by patients with severe forms of the disease, who remain uncontrolled and have frequent exacerbations, even with the … |
View full post on asthma – Google News
The Pharma Letter |
Global asthma market to hit $18 billion by 2021 boosted by biologics
The Pharma Letter Natasha Spiller, an analyst at Datamonitor Healthcare said: “Severe asthma remains a significant cause of mortality and morbidity and a portion of patients remain inadequately treated, despite the use of inhaled corticosteroids and long-acting beta 2 … |
View full post on asthma – Google News
|
Letter: Back to School With Asthma
Virginia Connection Newspapers Back to school season is upon us! For many families, there's more to do than sign up for activities and shop for supplies: 2,277 kids in Alexandria, 3,155 in Arlington, 417 in Fairfax City, and 23,441 in Fairfax County have asthma. Asthma accounts for … |
View full post on asthma – Google News